Team:Aachen/Parts
From 2014.igem.org
(→K1319002) |
(→iGEM Team Aachen Biobrick overview) |
||
(37 intermediate revisions not shown) | |||
Line 4: | Line 4: | ||
This page lists the collection of BioBricks developed by our team for the project ''Cellock Holmes - A Case of Identity''. | This page lists the collection of BioBricks developed by our team for the project ''Cellock Holmes - A Case of Identity''. | ||
+ | |||
+ | <center> | ||
+ | {| class="wikitable" | ||
+ | ! BioBrick !! Description | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319000 K1319000] | ||
+ | ||RFC[25] version of E0030 | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319001 K1319001] | ||
+ | ||RFC[25]-compatible dark quencher based on K1319000 (E0030) | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319002 K1319002] | ||
+ | ||RFC[25]-compatible dark quencher based on K1319000 (E0030) | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319003 K1319003] | ||
+ | ||human galectin-3, codon optimized for ''E. coli'' | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319004 K1319004] | ||
+ | ||TEV protease with anti-self cleavage mutation S219V, codon optimized for ''E. coli'' | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319008 K1319008] | ||
+ | ||IPTG-induced and T7-driven expression of TEV protease | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319009 K1319009] | ||
+ | ||mRFP-galectin3-his fusion protein CDS | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319010 K1319010] | ||
+ | ||Constitutive expression of K1319000 | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319011 K1319011] | ||
+ | ||Constitutive expression of K1319001 | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319012 K1319012] | ||
+ | ||Constitutive expression of K1319002 | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319013 K1319013] | ||
+ | ||Constitutive expression of GFP-REACh1 fusion protein | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319014 K1319014] | ||
+ | ||Constitutive expression of GFP-REACh2 fusion protein | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319015 K1319015] | ||
+ | ||Constitutive expression of GFP-EYFP fusion protein | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319016 K1319016] | ||
+ | ||TEV protease cleavage site | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319017 K1319017] | ||
+ | ||LasI induced iLOV | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319020 K1319020] | ||
+ | ||Translational unit of mRFP-galectin3-his | ||
+ | |- | ||
+ | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319042 K1319042] | ||
+ | ||IPTG inducible iLOV | ||
+ | |} </center> | ||
Line 97: | Line 153: | ||
This PCR also positively identified K1319008. Additionally both parts were sequenced. The sequencing data for [http://parts.igem.org/Part:BBa_K1319008 K1319008] and [http://parts.igem.org/Part:BBa_K1319013 K1319013] can be found in the parts registry. | This PCR also positively identified K1319008. Additionally both parts were sequenced. The sequencing data for [http://parts.igem.org/Part:BBa_K1319008 K1319008] and [http://parts.igem.org/Part:BBa_K1319013 K1319013] can be found in the parts registry. | ||
- | === | + | ===Characterization of K1319001 with the iGEM Team Aachen [https://2014.igem.org/Team:Aachen/Project/2D_Biosensor 2D Biosensor]=== |
<center> | <center> | ||
<div class="figure" style="float:{{{align|center}}}; margin: 0px 10px 10px 40px; border:{{{border|0px solid #aaa}}};width:{{{width|500px}}};padding:10px 10px 0px 0px;"> | <div class="figure" style="float:{{{align|center}}}; margin: 0px 10px 10px 40px; border:{{{border|0px solid #aaa}}};width:{{{width|500px}}};padding:10px 10px 0px 0px;"> | ||
Line 192: | Line 248: | ||
This PCR also positively identified K1319008. Additionally both parts were sequenced. The sequencing data for [http://parts.igem.org/Part:BBa_K1319008 K1319008] and [http://parts.igem.org/Part:BBa_K1319014 K1319014] can be found in the parts registry. | This PCR also positively identified K1319008. Additionally both parts were sequenced. The sequencing data for [http://parts.igem.org/Part:BBa_K1319008 K1319008] and [http://parts.igem.org/Part:BBa_K1319014 K1319014] can be found in the parts registry. | ||
- | === | + | ===Characterization of K1319001 with the iGEM Team Aachen [https://2014.igem.org/Team:Aachen/Project/2D_Biosensor 2D Biosensor]=== |
<center> | <center> | ||
<div class="figure" style="float:{{{align|center}}}; margin: 0px 10px 10px 40px; border:{{{border|0px solid #aaa}}};width:{{{width|500px}}};padding:10px 10px 0px 0px;"> | <div class="figure" style="float:{{{align|center}}}; margin: 0px 10px 10px 40px; border:{{{border|0px solid #aaa}}};width:{{{width|500px}}};padding:10px 10px 0px 0px;"> | ||
Line 213: | Line 269: | ||
<span class="anchor" id="partsK1319003"></span> | <span class="anchor" id="partsK1319003"></span> | ||
- | === | + | ===Human galectin-3, codon-optimized for ''E. coli''=== |
- | + | Galectin-3 is a 26 kDa protein that binds certain LPS patterns. It especially bind the O-section of the LPS. | |
Galectins are proteins of the lectin family, which posess '''carbonhydrate recognition domains''' binding specifically to β-galactoside sugar residues. In humans, 10 different galectines have been identified, among which is galectin-3. | Galectins are proteins of the lectin family, which posess '''carbonhydrate recognition domains''' binding specifically to β-galactoside sugar residues. In humans, 10 different galectines have been identified, among which is galectin-3. | ||
Line 222: | Line 278: | ||
Human galectin-3 is a protein of the lectin-family that was shown to bind the LPS of multiple human pathogens. | Human galectin-3 is a protein of the lectin-family that was shown to bind the LPS of multiple human pathogens. | ||
- | Some of them, including '' | + | Some of them, including ''Pseudomonas aeruginosa'' protect themselves against the human immune system by mimicking the lipopolysaccharides (LPS) present on human erythrocytes. |
+ | ===Usage and Biology=== | ||
+ | |||
+ | K1319003 was used to create [http://parts.igem.org/Part:BBa_K1319020 K1319020], a Galectin-mRFP fusion protein with a C-terminal His tag in the [https://2014.igem.org/Team:Heidelberg/Team/Collaborations Heidelberger expression vector] pSBX1A3. | ||
+ | |||
+ | We also cloned our K1319003 into the pET17 expression vector and expressed all combinations of fusion proteins in E. coli BL21(DE3). An SDS-PAGE showed that all fusion proteins were fully translated: | ||
+ | <center> | ||
+ | <div class="figure" style="float:{{{align|center}}; margin: 0px 10px 10px 0px; border:{{{border|0px solid #aaa}}};width:{{{width|800px}}};padding:10px 10px 0px 0px;"> | ||
+ | {| | ||
+ | |<html> <img src="https://static.igem.org/mediawiki/2014/thumb/5/52/Aachen_14-10-04_Expression_Pellets_iMO.png/425px-Aachen_14-10-04_Expression_Pellets_iMO.png" width="400px"></html> | ||
+ | |- | ||
+ | |'''{{{title|Pellets of different fusion protein expressions}}}'''<br />{{{subtitle|Expression in the pET17 vector was much more leaky than the expression in the pSBX vectors.}}} | ||
+ | |} | ||
+ | </div> | ||
+ | </center> | ||
+ | <html></br></html> | ||
+ | <center> | ||
+ | <div class="figure" style="float:{{{align|center}}; margin: 0px 10px 10px 0px; border:{{{border|0px solid #aaa}}};width:{{{width|800px}}};padding:10px 10px 0px 0px;"> | ||
+ | {| | ||
+ | |<html> <img src="https://static.igem.org/mediawiki/2014/thumb/6/62/Aachen_Gal3_Expression.png/425px-Aachen_Gal3_Expression.png" width="400px"></html> | ||
+ | |- | ||
+ | |'''{{{title|SDS-PAGE of K1319020 expression}}}'''<br />{{{subtitle|The fusion protein was fully translated to the correct molecular mass of 74 kDa.}}} | ||
+ | |} | ||
+ | </div> | ||
+ | </center> | ||
{{Team:Aachen/BlockSeparator}} | {{Team:Aachen/BlockSeparator}} | ||
Line 229: | Line 309: | ||
<span class="anchor" id="partsK1319004"></span> | <span class="anchor" id="partsK1319004"></span> | ||
- | ===TEV protease with anti-self cleavage mutation S219V, codon optimized for ''E. coli''=== | + | ===TEV protease with anti-self cleavage mutation S219V, codon-optimized for ''E. coli''=== |
+ | |||
+ | This part is a TEV protease in RFC25 that was optimized for expression in E. coli. The part contains the S219V anti-self cleavage mutation. | ||
- | |||
- | |||
The TEV Protease (also known as Tobaco Edge Virus nuclear inclusion a endopeptidase) is a highly sequence specific cysteine protease from the Tobacco Edge Virus (TEV). The protease is highly sequence specific. The consensus sequence for the cut is ENLYFQ\S with \ denoting the cleaved peptide bond. This sequence can be found in the part [http://parts.igem.org/Part:BBa_K1319016 K1319016]. | The TEV Protease (also known as Tobaco Edge Virus nuclear inclusion a endopeptidase) is a highly sequence specific cysteine protease from the Tobacco Edge Virus (TEV). The protease is highly sequence specific. The consensus sequence for the cut is ENLYFQ\S with \ denoting the cleaved peptide bond. This sequence can be found in the part [http://parts.igem.org/Part:BBa_K1319016 K1319016]. | ||
Line 239: | Line 319: | ||
The TEV protease is commonly used as a biochemical tool to cleave affinity tags from purified proteins like [http://parts.igem.org/Part:BBa_K1319007 His-Tags]. The high specifity makes the protease relatively non-toxic ''in vitro'' and ''in vivo''. The molecular weight of the TEV protease is 27 kDa. | The TEV protease is commonly used as a biochemical tool to cleave affinity tags from purified proteins like [http://parts.igem.org/Part:BBa_K1319007 His-Tags]. The high specifity makes the protease relatively non-toxic ''in vitro'' and ''in vivo''. The molecular weight of the TEV protease is 27 kDa. | ||
+ | ===Usage and Biology=== | ||
+ | |||
+ | The TEV Protease was used and characterizes in the [http://parts.igem.org/Part:BBa_K1319008 K1319008] construct. | ||
+ | |||
+ | To characterize the TEV protease we used the fusion protein [http://parts.igem.org/Part:BBa_K1319014 K1319014]. This fusion protein contains GFP ([http://parts.igem.org/Part:BBa_E0040 E0040]) bound to a dark quencher ([http://parts.igem.org/Part:BBa_K1319002 REACh2/K1319002]) over a [http://parts.igem.org/Part:BBa_K1319016 linker] which includes the TEV protease cleavage site. If the TEV protease successfully cuts the linker, GFP and its quencher would separate and the FRET (Förster Resonance Energy Transfer) system would be shut down. This would result in an increased GFP fluorescence. | ||
+ | |||
+ | To demonstrate this behaviour a double plasmid system was designed using the biobrick K1319013 in a pSB3K3 backbone and K1319008 in a pSB1C3 backbone. Also [http://parts.igem.org/Part:BBa_I20260 I20260] was used as a positive control because it produces the same GFP as used in the fusion protein and is regulated by the same promoter, RBS and Terminator on the same plasmid backbone. [http://parts.igem.org/Part:BBa_B0015 B0015] was used as negative control. Induction of the double plasmid constructs occured after 2 h with 50 µl of 100mM IPTG in a 50 ml shake flask culture. | ||
+ | |||
+ | <center> | ||
+ | <div class="figure" style="float:{{{align|center}}}; margin: 0px 10px 10px 0px; border:{{{border|0px solid #aaa}}};width:{{{width|800px}}};padding:10px 10px 0px 0px;"> | ||
+ | {| | ||
+ | |<html> <img src="https://static.igem.org/mediawiki/2014/3/3e/Aachen_Graph2_14.PNG" width="800px"></html> | ||
+ | |- | ||
+ | |'''{{{title|Comparison of the fluorescence adjusted for OD of I20260, B0015 and the double plasmid system K1319014 + K1319008}}}'''<br />{{{subtitle|After induction with IPTG after 2 h the double plasmid system produced a fast fluorescence response with an over 10-fold increase compared to the non induced state. I20260 served as positive control and B0015 as negative control.}}} | ||
+ | |} | ||
+ | </div> | ||
+ | </center> | ||
+ | <html></br></html> | ||
+ | |||
+ | The increase in fluorescence after induction with IPTG is clear sign of funtional expression of the TEV protease. The difference between not induced and induced plasmid is proof that the increase in fluorescence is only attributed to the successful cleavage of the linker. Therefore this is proof of a functional expression of the TEV protease after induction with IPTG. | ||
+ | |||
+ | Furthermore we validated the used plasmid with a Check PCR with one primer binding upstream on the plasmid backbone and one specifically in the insert. | ||
+ | |||
+ | <center> | ||
+ | <div class="figure" style="float:{{{align|center}}}; margin: 0px 10px 10px 0px; border:{{{border|0px solid #aaa}}};width:{{{width|500px}}};padding:10px 10px 0px 0px;"> | ||
+ | {| | ||
+ | |<html> <img src="https://static.igem.org/mediawiki/2014/0/0c/Aachen_K1319008_Gel_Check_PCR.png" width="500px"></html> | ||
+ | |- | ||
+ | |'''{{{title|Check PCR for K1319008}}}'''<br />{{{subtitle|The length of the PCR product matches the length of the control plasmid.}}} | ||
+ | |} | ||
+ | </div> | ||
+ | </center> | ||
+ | <html></br></html> | ||
+ | |||
+ | This validates that the construct is indeed the TEV protease and thereby the functionality of the TEV protease is established. The construct K1319008 was also sequenced. The sequencing data can be seen in the parts registry [http://parts.igem.org/Part:BBa_K1319008 here]. | ||
{{Team:Aachen/BlockSeparator}} | {{Team:Aachen/BlockSeparator}} | ||
Line 247: | Line 362: | ||
=== IPTG-induced and T7-driven expression of TEV protease === | === IPTG-induced and T7-driven expression of TEV protease === | ||
- | This protein generator produces the [http://parts.igem.org/Part:BBa_K1319004 | + | This protein generator produces TEV protease when induced with IPTG in a DE3 strain. |
+ | |||
+ | ===Usage and Biology=== | ||
+ | More information about the characterization of this part is available on the parts registry page for [http://parts.igem.org/Part:BBa_K1319004 K1319004]. This part was alos used in the validation and characterization of the parts [http://parts.igem.org/Part:BBa_K1319001 K1319001] and [http://parts.igem.org/Part:BBa_K1319001 K1319001]. | ||
This biobrick is used in our [https://2014.igem.org/Team:Aachen/Project/FRET_Reporter REACh construct]. | This biobrick is used in our [https://2014.igem.org/Team:Aachen/Project/FRET_Reporter REACh construct]. | ||
+ | |||
+ | |||
+ | {{Team:Aachen/BlockSeparator}} | ||
+ | |||
+ | |||
+ | ==[http://parts.igem.org/Part:BBa_K1319009 K1319009]== | ||
+ | |||
+ | ===mRFP-gal3-his fusion protein CDS=== | ||
+ | <span class="anchor" id="partsK1319009"></span> | ||
+ | |||
+ | This is a fusion protein created from E1010, K1319003 and K1319007. | ||
+ | |||
+ | |||
{{Team:Aachen/BlockSeparator}} | {{Team:Aachen/BlockSeparator}} | ||
Line 257: | Line 388: | ||
=== Constitutive expression of K1319000 === | === Constitutive expression of K1319000 === | ||
- | This part expresses K1319000 behind a J23101 constitutive promoter. | + | This part expresses [http://parts.igem.org/Part:BBa_K1319000 K1319000] behind a [http://parts.igem.org/Part:BBa_J23101 J23101] constitutive promoter. |
- | + | ||
{{Team:Aachen/BlockSeparator}} | {{Team:Aachen/BlockSeparator}} | ||
Line 314: | Line 444: | ||
===Constitutive expression of GFP-EYFP fusion protein=== | ===Constitutive expression of GFP-EYFP fusion protein=== | ||
- | This part expresses a [http://parts.igem.org/Part:BBa_E0040 E0040].[http://parts.igem.org/Part:BBa_K1319000 K1319000] fusion protein ( | + | This part expresses a [http://parts.igem.org/Part:BBa_E0040 E0040].[http://parts.igem.org/Part:BBa_K1319000 K1319000] fusion protein (GFP-EYFP) behind a [http://parts.igem.org/Part:BBa_J23101 J23101] promoter. |
Line 327: | Line 457: | ||
ENLYFQ\S is the optimal cleavage site with the highest activity but the protease is also active to a greater or lesser extent on a range of substrates. The highest cleavage is of sequences closest to the consensus EXLYΦQ\φ where X is any residue, Φ is any large or medium hydrophobic amino acid and φ is any small hydrophobic amino acid. | ENLYFQ\S is the optimal cleavage site with the highest activity but the protease is also active to a greater or lesser extent on a range of substrates. The highest cleavage is of sequences closest to the consensus EXLYΦQ\φ where X is any residue, Φ is any large or medium hydrophobic amino acid and φ is any small hydrophobic amino acid. | ||
+ | |||
+ | ===Usage and Biology=== | ||
+ | |||
+ | A TEV protease is available codon optimised for ''E. coli'' with the part [http://parts.igem.org/Part:BBa_K1319004 K1319004]. | ||
Line 346: | Line 480: | ||
===Translational unit of mRFP-galectin3-His=== | ===Translational unit of mRFP-galectin3-His=== | ||
- | This part is a translational unit of a mRFP-galectin-3- | + | This part is a translational unit of a mRFP-galectin-3-his (B0032.E1010.K1319003.K1319016.B0015) |
+ | |||
+ | ===Usage and Biology=== | ||
+ | |||
+ | For more information about the characterization of this part check out [http://parts.igem.org/Part:BBa_K1319003 K1319003]. | ||
Line 362: | Line 500: | ||
===iGEM Team Aachen Biobrick overview=== | ===iGEM Team Aachen Biobrick overview=== | ||
+ | |||
<groupparts>iGEM14 Aachen</groupparts> | <groupparts>iGEM14 Aachen</groupparts> | ||
{{Team:Aachen/Footer}} | {{Team:Aachen/Footer}} |
Latest revision as of 03:38, 18 October 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|